• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here

Category

All
  • Alle
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE
Clinical trials

Apixaban linked to lower recurrent venous thromboembolism hospitalization rate

subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Restoring the delicate coagulation balance in haemophilia
  • Non-myeloablative haploidentical haematopoietic stem cell transplantation for adult patients with sickle cell disease: Current status and future perspectives
  • Unveiling cytokine profiles: HLH induced by the combination of cemiplimab and venetoclax
  • Clinical importance of screening for the neglected acquired von Willebrand syndrome in patients with myeloproliferative neoplasms: A case series
  • Journal scan
  • New haematology reimbursements in Belgium
Pharma News

FDA approval for ciltacabtagene autoleucel for Relapsed/Refractory Multiple Myeloma

Science

Survival benefits with bortezomib in children with T-cell lymphoblastic leukaemia

Science

UBTF tandem duplication is a recurrent high-risk mutation in pediatric AML

Prevention

A new drug target to overcome obesity-induced chemoresistance in B-acute lymphoblastic leukaem...

Pharma News

FDA: major safety concerns with Ukoniq, PI3K inhibitor drug for treatment of lymphoma

Clinical trials

Consistent benefits of brentuximab vedotin plus chemotherapy for CD30-positive peripheral T-ce...

Previous 25 26 27 28 29 30 31 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025